Evidence map›Paper›PMID 34433115›Full record

ArticleEnvironment international2021

The effect of exposure to radiofrequency fields on cancer risk in the general and working population: A protocol for a systematic review of human observational studies.

Susanna Lagorio, Maria Blettner, Dan Baaken, Maria Feychting, Ken Karipidis, Tom Loney, Nicola Orsini, Martin Röösli, Marilia Silva Paulo, Mark Elwood

Abstract read
In one paragraph

Article in Environment international, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. Review
  5. Comorbidity, Eating Behaviors and Smartphone Addiction in Italian Nurses' Characteristics.Endocrine, metabolic & immune disorders drug targets · 2024
    Article
  6. Article
  7. Article
  8. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Susanna LagorioDepartment of Oncology and Molecular Medicine, National Institute of Health (Istituto Superiore di Sanità), Rome, Italy. Electronic address: susanna.lagorio@iss.it.
Maria BlettnerInstitute of Medical Biostatistics, Epidemiology and Informatics (IMBEI), University of Mainz, Germany. Electronic address: blettner@uni-mains.de.
Dan BaakenInstitute of Medical Biostatistics, Epidemiology and Informatics (IMBEI), University of Mainz, Germany. Electronic address: dabaaken@uni-mainz.de.
Maria FeychtingInstitute of Environmental Medicine, Karolinska Institutet, Stockholm, Sweden. Electronic address: maria.feychting@ki.se.
Ken KaripidisAustralian Radiation Protection and Nuclear Safety Agency (ARPANSA), Yallambie, VIC, Australia. Electronic address: ken.karipidis@arpansa.gov.au.
Tom LoneyCollege of Medicine, Mohammed Bin Rashid University of Medicine and Health Sciences, Dubai, United Arab Emirates. Electronic address: tom.loney@mbru.ac.ae.
Nicola OrsiniDepartment of Global Public Health, Karolinska Institutet, Stockholm, Sweden. Electronic address: nicola.orsini@ki.se.
Martin RöösliSwiss Tropical and Public Health Institute, Basel, Switzerland; University of Basel, Basel, Switzerland. Electronic address: martin.roosli@swisstpch.ch.
Marilia Silva PauloInstitute of Public Health, College of Medicine and Health Sciences, United Arab Emirates University, Al Ain, United Arab Emirates. Electronic address: mariliap@uaeu.ac.ae.
Mark ElwoodUniversity of Auckland, New Zealand. Electronic address: mark.elwood@auckland.ac.nz.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThe World Health Organization (WHO) has an ongoing project to assess potential health effects of exposure to radiofrequency electromagnetic fields (RF-EMF) in the general and working population. Here we present the protocol for a systematic review of the scientific literature on cancer hazards from exposure to RF-EMF in humans, commissioned by the WHO as part of that project.

objectiveTo assess the quality and strength of the evidence provided by human observational studies for a causal association between exposure to RF-EMF and risk of neoplastic diseases. ELIGIBILITY CRITERIA: We will include cohort and case-control studies investigating neoplasia risks in relation to three types of exposure to RF-EMF: near-field, head-localized, exposure from wireless phone use (SR-A); far-field, whole body, environmental exposure from fixed-site transmitters (SR-B); near/far-field occupational exposures from use of handheld transceivers or RF-emitting equipment in the workplace (SR-C). While no restriction on tumour type will be applied, we will focus on selected neoplasms of the central nervous system (brain, meninges, pituitary gland, acoustic nerve) and salivary gland tumours (SR-A); brain tumours and leukaemias (SR-B, SR-C). INFORMATION SOURCES: Eligible studies will be identified through Medline, Embase, and EMF-Portal. RISK-OF-BIAS ASSESSMENT: We will use a tailored version of the OHAT's tool to evaluate the study's internal validity. DATA SYNTHESIS: We will consider separately studies on different tumours, neoplasm-specific risks from different exposure sources, and a given exposure-outcome pair in adults and children. When a quantitative synthesis of findings can be envisaged, the main aims of the meta-analysis will be to assess the strength of association and the shape of the exposure-response relationship; to quantify the degree of heterogeneity across studies; and explore the sources of inconsistency (if any). When a meta-analysis is judged inappropriate, we will perform a narrative synthesis, complemented by a structured tabulation of results and appropriate visual displays. EVIDENCE ASSESSMENT: Confidence in evidence will be assessed in line with the GRADE approach.

fundingThis project is supported by the World Health Organization. Co-financing was provided by the New Zealand Ministry of Health; the Istituto Superiore di Sanità in its capacity as a WHO Collaborating Centre for Radiation and Health; ARPANSA as a WHO Collaborating Centre for Radiation Protection. REGISTRATION: PROSPERO CRD42021236798.

Indexed as

Brain NeoplasmsCell PhoneAdultChildElectromagnetic FieldsEnvironmental ExposureHumansMeta-Analysis as TopicRadio WavesAcoustic neuromaBase stationsBrain cancerBroadcast transmittersCase-control studiesChildhood leukaemiaCohort studiesCordless phonesEpidemiologyGliomaLeukaemiaMeningiomaMicrowavesMobile phonesNeoplasmsOccupational exposurePituitary tumoursRadiofrequency electromagnetic fieldsSalivary gland tumoursSystematic review protocol

Identifiers

PMID34433115
PMCPMC8484862

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.